Your browser doesn't support javascript.
loading
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group.
Ünal, Çaglar; Azizy, Abdulmunir; Karabulut, Senem; Tastekin, Didem; Akyildiz, Arif; Yasar, Serkan; Yalçin, Suayib; Çoban, Eyüp; Evrensel, Türkkan; Kalkan, Ziya; Oruç, Zeynep; Derin, Sümeyra; Turna, Zeynep Hande; Bayram, Dogan; Kös, Fahriye Tugba; Sendur, Mehmet Ali Nihat; Sever, Nadiye; Ercelep, Özlem; Seyyar, Mustafa; Kefeli, Umut; Uygun, Kazim; Özçelik, Melike; Ön, Sercan; Sanli, Ulus Ali; Canaslan, Kübra; Ünek, Ilkay Tuba; Yücel, Kadriye Bir; Özdemir, Nuriye; Yazici, Ozan; Güzel, Halil Göksel; Salim, Derya Kivrak; Göksu, Sema Sezgin; Tatli, Ali Murat; Ordu, Çetin; Selvi, Oguzhan; Sakin, Abdullah; Büyükbayram, Mehmet Emin; Dursun, Bengü; Ürün, Yüksel; Arak, Haci; Agdas, Gözde; Ugrakli, Muzaffer; Hendem, Engin; Eryilmaz, Melek Karakurt; Bilgin, Burak; Topçu, Atakan; Simsek, Melih; Büyüksimsek, Mahmut; Akay, Büsra; Erdal, Gülçin Sahingöz.
Affiliation
  • Ünal Ç; Division of Medical Oncology, Department of Internal Medicine, Kartal Dr. Lütfi Kirdar City Hospital, Istanbul, Turkey.
  • Azizy A; Division of Medical Oncology, Department of Internal Medicine, Istanbul University Institute of Oncology, Istanbul, Turkey.
  • Karabulut S; Division of Medical Oncology, Department of Internal Medicine, Istanbul University Institute of Oncology, Istanbul, Turkey.
  • Tastekin D; Division of Medical Oncology, Department of Internal Medicine, Istanbul University Institute of Oncology, Istanbul, Turkey.
  • Akyildiz A; Division of Medical Oncology, Department of Internal Medicine, Hacettepe University Institute of Oncology, Ankara, Turkey.
  • Yasar S; Division of Medical Oncology, Department of Internal Medicine, Hacettepe University Institute of Oncology, Ankara, Turkey.
  • Yalçin S; Division of Medical Oncology, Department of Internal Medicine, Hacettepe University Institute of Oncology, Ankara, Turkey.
  • Çoban E; Division of Medical Oncology, Department of Internal Medicine, Uludag University Hospital, Bursa, Turkey.
  • Evrensel T; Division of Medical Oncology, Department of Internal Medicine, Uludag University Hospital, Bursa, Turkey.
  • Kalkan Z; Division of Medical Oncology, Department of Internal Medicine, Dicle University Hospital, Diyarbakir, Turkey.
  • Oruç Z; Division of Medical Oncology, Department of Internal Medicine, Dicle University Hospital, Diyarbakir, Turkey.
  • Derin S; Division of Medical Oncology, Department of Internal Medicine, Cerrahpasa University Hospital, Istanbul, Turkey.
  • Turna ZH; Division of Medical Oncology, Department of Internal Medicine, Cerrahpasa University Hospital, Istanbul, Turkey.
  • Bayram D; Division of Medical Oncology, Department of Internal Medicine, Ankara City Hospital, Ankara, Turkey.
  • Kös FT; Division of Medical Oncology, Department of Internal Medicine, Ankara City Hospital, Ankara, Turkey.
  • Sendur MAN; Division of Medical Oncology, Department of Internal Medicine, Ankara City Hospital, Ankara, Turkey.
  • Sever N; Division of Medical Oncology, Department of Internal Medicine, Marmara University Hospital, Istanbul, Turkey.
  • Ercelep Ö; Division of Medical Oncology, Department of Internal Medicine, Marmara University Hospital, Istanbul, Turkey.
  • Seyyar M; Division of Medical Oncology, Department of Internal Medicine, Kocaeli University Hospital, Kocaeli, Turkey.
  • Kefeli U; Division of Medical Oncology, Department of Internal Medicine, Kocaeli University Hospital, Kocaeli, Turkey.
  • Uygun K; Division of Medical Oncology, Department of Internal Medicine, Kocaeli University Hospital, Kocaeli, Turkey.
  • Özçelik M; Division of Medical Oncology, Department of Internal Medicine, Ümraniye Research and Training Hospital, Istanbul, Turkey.
  • Ön S; Division of Medical Oncology, Department of Internal Medicine, Ege University Hospital, Izmir, Turkey.
  • Sanli UA; Division of Medical Oncology, Department of Internal Medicine, Ege University Hospital, Izmir, Turkey.
  • Canaslan K; Division of Medical Oncology, Department of Internal Medicine, Dokuz Eylül University Hospital, Izmir, Turkey.
  • Ünek IT; Division of Medical Oncology, Department of Internal Medicine, Dokuz Eylül University Hospital, Izmir, Turkey.
  • Yücel KB; Division of Medical Oncology, Department of Internal Medicine, Gazi University Hospital, Ankara, Turkey.
  • Özdemir N; Division of Medical Oncology, Department of Internal Medicine, Gazi University Hospital, Ankara, Turkey.
  • Yazici O; Division of Medical Oncology, Department of Internal Medicine, Gazi University Hospital, Ankara, Turkey.
  • Güzel HG; Division of Medical Oncology, Department of Internal Medicine, Antalya Research and Training Hospital, Antalya, Turkey.
  • Salim DK; Division of Medical Oncology, Department of Internal Medicine, Antalya Research and Training Hospital, Antalya, Turkey.
  • Göksu SS; Division of Medical Oncology, Department of Internal Medicine, Akdeniz University Hospital, Antalya, Turkey.
  • Tatli AM; Division of Medical Oncology, Department of Internal Medicine, Akdeniz University Hospital, Antalya, Turkey.
  • Ordu Ç; Division of Medical Oncology, Department of Internal Medicine, Gayrettepe Florence Nightinagle Hospital, Istanbul, Turkey.
  • Selvi O; Division of Medical Oncology, Department of Internal Medicine, Okmeydani Research and Training Hospital, Istanbul, Turkey.
  • Sakin A; Division of Medical Oncology, Department of Internal Medicine, Bahçelievler Medipol Hospital, Istanbul, Turkey.
  • Büyükbayram ME; Division of Medical Oncology, Department of Internal Medicine, Ataturk University Hospital, Erzurum, Turkey.
  • Dursun B; Division of Medical Oncology, Department of Internal Medicine, Ankara University Hospital, Ankara, Turkey.
  • Ürün Y; Division of Medical Oncology, Department of Internal Medicine, Ankara University Hospital, Ankara, Turkey.
  • Arak H; Division of Medical Oncology, Department of Internal Medicine, Gaziantep University Hospital, Gaziantep, Turkey.
  • Agdas G; Division of Medical Oncology, Department of Internal Medicine, Osmangazi University Hospital, Eskisehir, Turkey.
  • Ugrakli M; Division of Medical Oncology, Department of Internal Medicine, Konya Meram University Hospital, Konya, Turkey.
  • Hendem E; Division of Medical Oncology, Department of Internal Medicine, Konya Meram University Hospital, Konya, Turkey.
  • Eryilmaz MK; Division of Medical Oncology, Department of Internal Medicine, Konya Meram University Hospital, Konya, Turkey.
  • Bilgin B; Division of Medical Oncology, Department of Internal Medicine, Konya City Hospital, Konya, Turkey.
  • Topçu A; Division of Medical Oncology, Department of Internal Medicine, Bezmialem Vakif University Hospital, Istanbul, Turkey.
  • Simsek M; Division of Medical Oncology, Department of Internal Medicine, Bezmialem Vakif University Hospital, Istanbul, Turkey.
  • Büyüksimsek M; Division of Medical Oncology, Department of Internal Medicine, Adana Research and Training Hospital, Adana, Turkey.
  • Akay B; Division of Medical Oncology, Department of Internal Medicine, Ankara Yurtaslan City Hospital, Ankara, Turkey.
  • Erdal GS; Division of Medical Oncology, Department of Internal Medicine, Bakirköy Sadi Konuk Research and Training Hospital, Istanbul, Turkey.
Oncologist ; 28(10): 875-884, 2023 10 03.
Article in En | MEDLINE | ID: mdl-37676712

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroendocrine Tumors Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: Turkey

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroendocrine Tumors Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: Turkey